US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biotechnology Company Reports: research reports

Research your competitors and discover new corporate prospects in the biotechnology industry with company reports and profiles.
RSS Feeds

Biotechnology Company Reports market research reports and industry analysis

< prev 1    3  4  5  6  7  8  9  10  
Physician Views: How do oncologists expect use of Kyprolis will be affected by Amgen's positive ASPIRE data?
8/14/2014 | published by: FirstWord
... myeloma patients, thus greatly multiplying the drug's commercial potential. In the three quarters since the deal closed, investors have put up with relatively unremarkable sales growth for Kyprolis but have been getting antsy waiting for ...  |  read more...
USD 645
Molecular Templates Inc. - Product Pipeline Review - 2014
8/25/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Molecular Templates Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Biotechnology in the United Kingdom
8/12/2014 | published by: Plimsoll Publishing Ltd.
... activities such as dna, contract pharmaceutical drug development services, biotechnology, microbiology, hygiene and includes a wealth of information on the financial trends over the past four years. latest Biotechnology analysis is perfect for investors to: ...  |  read more...
USD 525
Metabolon, Inc. - Product Pipeline Analysis, 2014 Update
8/13/2014 | published by: GlobalData
... Metabolon's Quantose IR test is a blood test performed for detecting early-stage insulin resistance; and Prostarix and Prostarix Plus tests are urine-based tests used in the detection of prostate cancer risk. The company partners with ...  |  read more...
USD 750
Pharming Group N.V. (PHARM) - Financial and Strategic SWOT Analysis Review
7/22/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Sinovac Biotech Ltd. - Product Pipeline Review - 2014
7/22/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Sinovac Biotech Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Biotech Financial Reports August 2014
8/1/2014 | published by: Worldwide Videotex
BIOTECH FINANCIAL REPORTS provides the latest financial information and news on biotech and pharmaceutical companies. This includes quarterly and annual reports plus merger and acquisition news, and stock dividend announcements.  |  read more...
USD 25
Worldwide Biotech August 2014
8/1/2014 | published by: Worldwide Videotex
... an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors the emerging European Community marketplace and the growing Japanese interest and deals in the U.S. biotechnology and pharmaceuticals industry.  |  read more...
USD 25
Acorda Therapeutics Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... the information you require to better understand Acorda Therapeutics and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up ...  |  read more...
USD 995
Alkermes Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... you require to better understand Alkermes and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
USD 995
Amgen Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying ...  |  read more...
USD 995
Anika Therapeutics Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... the information you require to better understand Anika Therapeutics and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up ...  |  read more...
USD 995
Biogen Idec Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding ...  |  read more...
USD 995
Celgene Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying ...  |  read more...
USD 995
Dendreon Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... you require to better understand Dendreon and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
USD 995
Genentech Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying ...  |  read more...
USD 995
Genmab Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... you require to better understand Genmab and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
USD 995
Genzyme Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying ...  |  read more...
USD 995
Intermune Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... you require to better understand Intermune and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
USD 995
Nektar Therapeutics Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... the information you require to better understand Nektar Therapeutics and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up ...  |  read more...
USD 995
Novartis Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... require to better understand Novartis and its partnering interests and activities over the past five years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and ...  |  read more...
USD 995
Marketed Stage Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
USD 1,495
Clinical Stage Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
USD 1,495
Discovery Stage Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
USD 1,495
Public Health Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
USD 1,495
< prev 1    3  4  5  6  7  8  9  10